New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

China New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4, Find details about China 1038915-60-4, CAS 1038915-60-4 from New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

Model NO.
1038915-60-4
Storage Condition
Store at Rt
Trademark
Fousi
Transport Package
Aluminium Foil Bag
Specification
KG
Origin
China
Model NO.
1038915-60-4
Storage Condition
Store at Rt
Trademark
Fousi
Transport Package
Aluminium Foil Bag
Specification
KG
Origin
China

 

New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

New Anti-Cancer Niraparib Tosylate Monohydrate Powder
CAS 1038915-60-4
Product Description

Product Introduction:
Niraparib  is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer. 
The drug is approved by the US FDA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.

 

Product Name Niraparib
CAS No.1038915-60-4
Purity99%
Grade Standard Veterinary Drug Standard 
MFC19H20N4O
MW320.39
Test Method HPLC
Other Name Niraparib Powder
Appearance White Powder
BrandMT
 
Product picture

 

New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

 

Product Parameters

Applications:
Niraparib is a small molecule inhibitor of poly ADP-ribose polymerase that is used in the therapy of selected patients with refractory and advanced ovarian carcinoma.
Niraparib therapy is associated with a low rate of transient elevations in serum aminotransferase during therapy, but has not been linked to instances of clinically apparent liver injury.

 
Packaging & Shipping

New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

Company Profile

 

New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4
 
FAQ

 

New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4